Drug Slows Brain Shrinkage in Progressive MS Patients by Nearly Half

A team led by researchers from the Cleveland Clinic's Neurological Institute reports that a promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half. Limited therapies are currently available for this disabling form of the disease, according to the scientists.The definitive results of the Phase II trial (“ Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis ”), published in the  New England Journal of Medicine,  showed that the dr